By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Prothena Corporation plc 

25-28 North Wall Quay

  Dublin  1  Ireland
Phone: 353-1-902-3519 Fax: 353-1-902-3510


SEARCH JOBS


Industry
Biotechnology






Company News
Prothena Receives FDA Fast Track Designation For NEOD001, A Monoclonal Antibody For The Treatment Of Patients With AL Amyloidosis 12/15/2014 10:53:45 AM
Prothena Corporation plc To Present At The Oppenheimer 25th Annual Healthcare Conference In New York 12/9/2014 12:26:33 PM
GUEST COLUMN: Does Size Kill Culture? Prothena Doesn’t Think So 12/8/2014 10:29:51 AM
Prothena Corporation plc Initiates NEOD001 Global Phase 3 Registrational Trial Based On Positive Results In Ongoing Phase 1/2 Study Of NEOD001 In Patients With AL Amyloidosis 12/3/2014 11:14:20 AM
Prothena Corporation plc CEO Diagnosed With Pancreatic Cancer 12/3/2014 8:27:30 AM
Prothena Corporation plc Targets Rare Protein-Misfolding Disease In Late-Stage Study 12/3/2014 7:01:29 AM
Prothena Corporation plc Reports Third Quarter 2014 Financial Results And R&D Progress 11/4/2014 7:50:46 AM
Prothena Corporation plc Announces Presentation At Federation Of European Physiological Societies 2014 Congress 8/27/2014 8:02:43 AM
Prothena Corporation plc Release: Dr. Dale Schenk To Discuss Parkinson's Disease At 2014 Rejuvenation Biotechnology Conference 8/19/2014 6:53:18 AM
Prothena Corporation plc Reports Second Quarter 2014 Financial Results And R&D Progress 8/4/2014 3:45:15 PM
1234
//-->